First domino, named next dominoes: management generalizes a fresh win into a repeatable template and points to the speci
The model's full reasoning — Q4 2022 call → NOWe need to determine if management explicitly generalizes a recent real success as a repeatable template and identifies specific next places where it's being applied. Scan the transcript for such a pattern. Management discusses many successes: EYLEA, Dupixent, Libtayo, aflibercept 8mg, oncology pipeline, etc. But the question asks for a specific instance where they say "what we just did is a template" and point to specific next applications. Look for language like "template", "repeat", "blueprint", "playbook", "we can apply this to", "we are now doing this in", etc. In the transcript, George Yancopoulos talks about the costimulatory bispecifics and the PSMAxCD28 data. He says: "we have validated individual agents... we are now going to be rolling out data from these combinations... we are going to be reporting on a series of other costims... we are going to be initiating combination with these costim bispecifics." But is that a proven first instance? The PSMAxCD28 is early data, not a full success. Also, he doesn't explicitly say "this is a template" but rather describes a platform approach. However, the question requires that the first instance is a real success that has actually achieved something concrete. The PSMAxCD28 data is early, with 3 out of 4 patients at highest dose showing >90% reduction in PSA. That is a real result, but is it a "won customer, completed project, deployment, successful product introduction"? It's a clinical trial result, not a commercial success. The question says "a won customer, a completed project or deployment, a successful product introduction, a first site, market, program, or partnership that is now demonstrably working and producing real business." Clinical trial results are not business success. So that likely doesn't qualify. Another possibility: Dupixent approvals. They mention approvals in new indications and geographies. But they don't explicitly say "this is a template" and point to specific next places. They talk about expanding to more indications, but that's a general pipeline. Look for a specific instance where they say "we did X, and now we are doing Y, Z" with Y and Z being specific and already in motion. For example, in the oncology section, they mention Libtayo combination with LAG-3, and they are moving to lung cancer and other solid tumors.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| MCD | McDonald's Corporation | Q2 2024 | 2024-07-29 | D |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| GOLD | Barrick Gold Corporation | Q3 2023 | 2023-11-02 | C |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| UPWK | Upwork Inc. | Q2 2022 | 2022-07-27 | C+ |
| LOW | Lowe's Companies, Inc. | Q3 2021 | 2021-11-17 | B+ |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| ACHC | Acadia Healthcare Company, Inc. | Q4 2017 | 2018-02-22 | C+ |
T · Q3 2018 → YESThe question is: Does management take a RECENT, REAL SUCCESS and explicitly GENERALIZE it as a template they can repeat, AND identify SPECIFIC NEXT PLACES where that template is already being applied?...YES The transcript shows management treating the AdWorks success (22% revenue growth on a declining subscriber base) as a proven template for targeted advertising, then explicitly identifying the next applications: applying the same technology to Turner inventory and signing up additional distributors (Frontier and Altice) as concrete next repetitions already in motion. 5G and FirstNet do not qualify because their first instances are still prospective or ongoing without a completed, repeatable proof-of-concept.
LOW · Q3 2021 → YESThe question is about whether management takes a recent real success and generalizes it as a template they're applying to specific next places. YES The transcript shows management treating the market-based delivery model as a proven template after the first success in Florida and the second in Ohio Valley this quarter. They explicitly generalize it as a repeatable approach that is already driving measurable results (higher sales in appliances, improved margins, reduced inventory, higher on-time delivery) and plan 18+ months of rollout across the entire US.
FLR · Q2 2022 → YESThe question is about whether management takes a recent, real success and generalizes it as a template they can repeat, and identifies specific next places where it's being applied. YES The transcript shows management treating the LNG 1 project (awarded last quarter) as a proven template: David Constable states they have “proven that our mid-scale modular design and execution plans facilitates repeatable models that can be used to replicate and fast track similar LNG plants in the future.